Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Volitionrx (VNRX) Beginning Cash Balance (2019 - 2020)

Volitionrx filings provide 4 years of Beginning Cash Balance readings, the most recent being $17.0 million for Q1 2020.

On a quarterly basis, Beginning Cash Balance rose 26.36% to $17.0 million in Q1 2020 year-over-year; TTM through Mar 2020 was $17.0 million, a 16029.74% increase, with the full-year FY2013 number at $54396.0, down 46.96% from a year prior.
Beginning Cash Balance hit $17.0 million in Q1 2020 for Volitionrx, up from $13.4 million in the prior quarter.
In the past five years, Beginning Cash Balance ranged from a high of $17.0 million in Q1 2020 to a low of $13.4 million in Q1 2019.